Absence of the intracellular lipolytic inhibitor G0S2 enhances intravascular triglyceride clearance and abolishes diet-induced hypertriglyceridemia
Open Access
- 18 March 2025
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (10)
Abstract
The interplay between intracellular and intravascular lipolysis is crucial for maintaining circulating lipid levels and systemic energy homeostasis. Adipose triglyceride lipase (ATGL) and lipoprotein lipase (LPL), the primary triglyceride (TG) lipases responsible for these two spatially separate processes, are highly expressed in adipose tissue. Yet the mechanisms underlying their coordinated regulation remain undetermined. Here, we demonstrate that genetic ablation of G0S2, a specific inhibitory protein of ATGL, completely abolished diet-induced hypertriglyceridemia and significantly attenuated atherogenesis in mice. These effects were attributable to enhanced whole-body TG clearance, not altered hepatic TG secretion. Specifically, G0S2 deletion increased circulating LPL concentration and activity, predominantly through LPL production from white adipose tissue (WAT). Strikingly, transplantation of G0S2-deficient WAT normalized plasma TG levels in mice with hypertriglyceridemia. In conjunction with improved insulin sensitivity and decreased ANGPTL4 expression, the absence of G0S2 enhanced the stability of LPL protein in adipocytes, a phenomenon that could be reversed upon ATGL inhibition. Collectively, these findings highlight the pivotal role of adipocyte G0S2 in regulating both intracellular and intravascular lipolysis, and the possibility of targeting G0S2 as a viable pharmacological approach to reducing levels of circulating TGs.Keywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (DK109096, DK130331, DK007352, DK124190)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK109096, DK130331, DK007352, DK124190)
This publication has 49 references indexed in Scilit:
- Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout miceProceedings of the National Academy of Sciences, 2007
- Glycosylphosphatidylinositol-Anchored High-Density Lipoprotein-Binding Protein 1 Plays a Critical Role in the Lipolytic Processing of ChylomicronsCell Metabolism, 2007
- Insulin downregulates angiopoietin-like protein 4 mRNA in 3T3-L1 adipocytesBiochemical and Biophysical Research Communications, 2006
- Compensation for an increase in body fat caused by donor transplants into miceAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
- Characterization of the Fasting-induced Adipose Factor FIAF, a Novel Peroxisome Proliferator-activated Receptor Target GeneJournal of Biological Chemistry, 2000
- Surgical implantation of adipose tissue reverses diabetes in lipoatrophic miceJournal of Clinical Investigation, 2000
- Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivoJournal of Clinical Investigation, 1999
- A preadipose 3T3 cell variant highly sensitive to adipogenic factors and to human growth hormoneJournal of Cell Science, 1995
- Insulin Regulation of Lipoprotein Lipase Activity in 3T3-L1 Adipocytes is Mediated at Posttranscriptional and Posttranslational LevelsJournal of Biological Chemistry, 1989
- Insulin increases the synthetic rate and messenger RNA level of lipoprotein lipase in isolated rat adipocytes.Journal of Biological Chemistry, 1988